Released on: January 14, 2008, 4:05 pm

Press Release Author: Gerard Sunnen, MD

Industry: Healthcare

Press Release Summary: An international clinical study on hepatitis C is blocked

Press Release Body: New York, January 15, 2008 - A landmark study aimed at Egypt's
hepatitis C pandemic recruiting the collaboration of the National Research Centre
(NRC) in Cairo, Egypt, and Medizone International, Inc., a U.S. public company
engaged in developing complementary therapies for hepatitis C, was blocked by the
NYSDOH (New York State Department of Health).

According to Dr. Gérard Sunnen, former president and director of research for
Medizone, the NYSDOH stopped the study at a time when all contracts were signed and
study volunteers inEgypt had already been selected. ''The motives are clear. The
NYSDOH has a history of strongly suppressing complementary therapies. Also, special
interests are involved, potent economic forces fighting to keep the status quo on
established pharmaceutical pipelines," he said.

In Egypt, hepatitis C prevalence is the highest in the world. A vaccination program
gone awry provides a partial explanation for this massive infection rate. "The NRC,
responding to this huge public health crisis, contacted Medizone seeking its immune
activation technology. Conventional drug therapies are prohibitively costly for such
a large target population and are inordinately prone to failure and to serious side
effects. The Medizone process, by contrast, is considerably less onerous," Dr.
Sunnen added.

"The rewards of this (failed) research would have extrapolated far beyond the
treatment of hepatitis C. Immune function enhancement is a bonus for a host of
diseases and could thus well complement current treatment options for several major
pathogenic viruses," said Dr. Sunnen.

"Special interests and other agendas can all too easily kill innovative medical
research," Dr. Sunnen concluded, adding, "when that happens, the public interest
invariably suffers and a little humanity is removed from each one of us."

CONTACT INFORMATION:

Gérard Sunnen, M.D.
Ozonics International, LLC
200 East 33 Street, Suite 26J
New York, NY 10016-4831 USA
Tel. 1-212-6790679 / Fax 1-212-6798008
Ozonicsint.com
GSunnen@aol.com

###







Web Site: http://Ozonicsint.com

Contact Details: Gerard Sunnen, MD
200 E. 33 St., 26J
New York, NY 10016
212-6790679
Gsunnen@aol.com